Nose-drop intoxication in an infant. 1970

R E Thompson

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014663 Nasal Decongestants Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) Decongestant,Decongestants,Nasal Decongestant,Vasoconstrictor Agents, Nasal,Vasoconstrictors, Nasal,Agents, Nasal Vasoconstrictor,Decongestant, Nasal,Decongestants, Nasal,Nasal Vasoconstrictor Agents,Nasal Vasoconstrictors

Related Publications

R E Thompson
December 1954, A.M.A. archives of otolaryngology,
R E Thompson
October 1971, California medicine,
R E Thompson
June 1990, Acta paediatrica Japonica : Overseas edition,
R E Thompson
October 2005, Forensic science international,
R E Thompson
July 1979, Chest,
R E Thompson
October 1997, Southern medical journal,
R E Thompson
November 1933, Proceedings of the Royal Society of Medicine,
R E Thompson
January 1958, Annals of allergy,
R E Thompson
May 1975, Clinical pharmacology and therapeutics,
R E Thompson
January 1975, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!